The healthcare and pharmaceuticals industry is defensive by nature given its necessity. Individuals need healthcare irrespective of economic conditions. With steady demand for medications, vaccines, and treatments, the industry is able to withstand the effects of economic recessions. Its resilience is complemented by aging populations and growing healthcare demands around the world.
For investors, the industry can protect against the volatility of the market, providing stable growth and constant returns due to its non-cyclical nature and ongoing innovation.
1. Divis
Divi’s Laboratories Limited is a top Indian pharmaceutical firm that produces and markets generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals worldwide. It also offers custom synthesis and contract manufacturing services. Divi’s has a robust overseas presence, with exports to countries in North America, Europe, Asia, and others.
The company reported a revenue of Rs 9,360 crores in FY25, up by 19.33 percent, from its FY24 revenue of Rs 7,845 crores. It reported a net profit growth of 36.94 percent to Rs 2,191 crores in FY25 from Rs 1,600 crores in FY24.
2. Cipla
Cipla Limited is a multinational pharmaceutical business that specializes in developing, manufacturing, and marketing generic and proprietary medicines, vaccines, and active pharmaceutical ingredients.
It operates in core markets such as India, the US, and South Africa, in therapeutic segments of respiratory, cardiovascular, diabetes, HIV/AIDS, oncology, and critical care. Cipla further engages in consumer healthcare, biosimilars, and specialty medicines, aiding prescription and over-the-counter segments.
The company reported a revenue of Rs 27,548 crores in FY25, up by 6.89 percent, from its FY24 revenue of Rs 25,774 crores. It reported a net profit growth of 26.87 percent to Rs 5,269 crores in FY25 from Rs 4,154 crores in FY24.
Also read: 2 Stocks to buy now for an upside of up to 18%; Recommended by Trade Brains portal – June 12
3. Max Healthcare Institute
Max Healthcare Institute Limited is primarily engaged in providing healthcare services through primary care clinics, multi-specialty hospitals / medical centers, and super-specialty hospitals providing operation and management, medical services, clinical, radiology, pathology services, and related healthcare services.
The company reported a revenue of Rs 7,028 crores in FY25, up by 30 percent, from its FY24 revenue of Rs 5,406 crores. It reported a net profit growth of 1.70 percent to Rs 1,076 crores in FY25 from Rs 1,058 crores in FY24.
4. Fortis Healthcare
Fortis Health Ltd. is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics, and daycare specialty facilities. It has 27 healthcare facilities with approximately 4,750 operational beds.
The company reported a revenue of Rs 7,783 crores in FY25, up by 13 percent, from its FY24 revenue of Rs 6,893 crores. It reported a net profit growth of 25 percent to Rs 809 crores in FY25 from Rs 645 crores in FY24.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
